The medical robotics market continues to grow at unprecedented rates. Between 2012 and 2018, the number of robot-assisted surgeries increased from 1.8 percent to 15.1 percent of all general procedures, and the trend continues. The market for medical robotics is currently valued at about $8 billion and expected to exceed $25 billion by 2025. More funding for medical robotics research and recent IPOs of surgical robotics companies are providing growth capital. Thus, it is not surprising that investments in medical robotics firms helped medical device funding top $5 billion in Q3 2020.
To compete in this hot market, it is important that both early stage and established companies have a strategic patent portfolio that can protect and monetize company innovations. For an early stage company, a strong patent portfolio is key to growth and survival and can help secure VC funding. For a large company, the patent portfolio can protect its position in the market, as well as facilitate partnership and cross-licensing opportunities. This presentation will provide attendees with practical strategies for building a strong patent portfolio, including:
* Business advantages of a strategic IP portfolio
* Patent strategy - offensive and defensive strategies, taking advantages of USPTO accelerated prosecution programs, strategies for foreign filing
* Focusing product development through knowledge of the patent landscape
* Securing ownership in and maintaining control of IP
* IP due diligence - being prepared for the tough questions
Dr. Partha Mitra, Ph.D., Founder & Chief Scientific Advisor, ClaraPath Inc.
Roman Fayerberg, Patent Attorney & Shareholder, Greenberg Traurig, LLP
Todd Basile, Patent Attorney & Shareholder, Greenberg Traurig, LLP
David J. Dykeman, Patent Attorney, Shareholder & Co-Chair, Life Sciences & Medical Technology Group, Greenberg Traurig, LLP